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Summary.-In 32 healthy blood donors, 20 patients with histologically verified
cancer and 18 patients with non-neoplastic diseases, the fluorescence polarization
changes of fluorescein samples incorporated in mononuclear leucocytes were mea-
sured after incubation with PHA. The leucocytes of healthy persons, and 16/18 per-
sons with non-neoplastic diseases, responded with a decrease in the degree of
fluorescence polarization by about 20% from that in non-PHA-stimulated cells. In
19/20 patients with a variety of malignant tumours, the leucocytes did not respond
to PHA stimulation with such a decrease. The exceptions among the patients with
neoplastic and non-neoplastic diseases are considered, and may not be "false-
negative" or "false-positive" respectively, but indicative of a particular situation in
that disease. The biophysical mechanisms underlying the observed changes remain
to be investigated.
It has been the purpose ofour studies to
investigate the influence of phytohaemag-
glutinin (PHA) on the fluorescence polar-
ization offluorescein samples incorporated
into mononuclear blood cells of normal
human beings, of patients with histo-
logically confirmed neoplasia, and of
patients with non-neoplastic diseases. Pre-
viously, Cercek, Cercek and Franklin
(1974) and Cercek and Cercek (1974, 1975,
1976) have published several reports which
suggest that changes in fluorescence polar-
ization after incubation of lymphocytes
with PHA or with cancer basic proteins
(CaBP) indicate specific changes of the
"structuredness of the cytoplasmic
matrix" (SCM). The "SCM-test", if it
could be reproduced and confirmed, would
represent a valuable tool in the early
recognition of neoplasia, perhaps long
before it could be detected by other means.
It would also be useful to study the very
early reactions of cells to foreign proteins
on the structuredness of cytoplasm. In a
recent workshop the potentialities of the
SCM test were discussed and method-
ological problems raised (Bagshawe, 1977).
Our studies show that there are fluor-
escence-polarization changes in mono-
nuclear blood cells after their incubation
with PHA which are absent when cells of
the same density characteristics from
patients with neoplasia are investigated.
Reproducibility and reliability of the
changes depend to a large extent on the
methods used, and the care taken in the
preparation of the cells for study. How-
ever, the mechanisms that lead to the
observed changes are far from being clear,
and require further investigation.
MATERIALS AND METHODS
Sources of mononuclear blood cells.-Mono-
nuclear blood cells were collected by drawing
20 ml of blood into heparinized polystyrene
syringes from a total of 70 human beings.
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The heparin concentration was 1000 iu/20 ml
ofblood (Liquemin 25000 from Hoffmann-La
Roche). Thirty-two blood samples came from
humanvolunteers without anyknowndisease,
who could be considered healthy by all
accepted criteria. These blood samples were
considered as from "normal controls" (Table
I). Twenty-one blood samples were from
patients with malignant tumours, the diag-
nosis of which was established by histo-
pathological examination. The histopatholog-
ical diagnoses are given in Table II. In 18
TABLE I.-Comparisons between
Healthy Individuals
Residual polarization as
percentage of the un-
stimulated control value*
No. Name Age 1st 2nd 3rd
1 HK 30 88 73 81
77 81 82
2 GL 31 87
3 HA 29 90 - --
4 WP 31 89 88
5 MP 41 73 89
6 KW 27 85 90
7 H-JG 28 87 86
8 USt 28 88 87
9 HM 32 78 87 -
10 MN 35 89 -
11 WS 29 77 -
12 KK 28 82 73 78
13 LOe 27 87
14 GF 52 91 -
15 HB 25 78
16 FR 30 81
17 HO 35 79 -
18 AG 28 82 81
19 ISch 27 80 83
20 EJ 26 77
21 NH 29 74
22 BK 30 79
23 HS 27 82
24 ES 37 88 84
25 AK 30 87 77 85
26 MS 28 78
27 WF 40 85 75
28 HJB 36 87 85 -
29 WK 26 87 -
30 OS 25 85 86
31 WG 25 78
32 DS 26 80
* 1st, 2nd and 3rd measurements were carried
out on different days.
The age of the healthy comparisons is lower than
that of the patients with neoplasia because it was
felt that the younger group is less likely to contain
persoins with undetected neoplasia that could distort
the pattern. The group of volunteers comprises
healthy associates ofour research group and ofother
laboratories ofour institutes. Only the first measure-
ments were used for Fig. 4.
TABLE II.-Patients with Malignant
Diseases
No.
I
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
a
b
Name Age
VG 77
ES 60
EU 69
MR
VP
AK
RB
AP
MH
BC
RR
EB
ER
US
EL
RS
HS
JS
IJ
FC
59
80
43
45
54
52
77
78
54
79
39
79
67
71
69
28
50
Residual
polarization
as percentage
of the
unstimulated
Diagnosis controlvalue
Adenoca rectum without
LN metastases 102
Adenoca colon 102
Ca gall bladder
with metastases to
the liver after surgical
removal 104
Ca rectum 101
Ca stomach 99
Ca sigma 101
Ca breast 102
Ca breast 104
Ca breast 103
Ca stomach 101
Ca stomach 100
Ca pancreas 106
Adeno ca rectum 105
Ca breast 102
Lymphoma of stomach 102
Ca pancreas 103
Ca rectum 99
Ca pancreas 102
Hodgkin's disease 103
Melanoma
1 day Iafter surgical 89
13 daysJ removal 88
of the 21 samples, blood was taken before
surgery. In the 3 exceptions (Nos. 3, 20a and
20b) the blood was removed after surgery (see
Table). In Table III, the clinical diagnoses
are given for those patients who did not
suffer from known malignancy, but were
admitted to the hospital for a variety of
other reasons. The majority of these patients
had infectious disease (bacterial, viral or
fungal) or other inflammatory conditions.
The blood was sampled and the cell sus-
pensions were prepared by a physician. The
measurements were all performed by a
physicist not knowing the medical condition
of the donor.
Preparation ofglassware.-Pilot studies had
indicated the need to prepare with utmost
care all materials that came in contact with
the cells to be studied. This included the
special cleaning and sterilization of glass
pipettes, test tubes, cuvettes, beakers, filtra-
tion tubes etc. The following procedure, as in
Cercek and Cercek (1977), was applied. All
the glassware was first immersed for at least
12 h in a 4% Extran(®) solution (Extran
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TABLE III.-Patients with Various
Non-malignant Diseases
a
No. Age
19
44
65
24
68
64
46
56
42
30
63
50
24
20
70
50
28
33
Diagnosis
Acute appendicitis
Fibroadenoma of breast
Polyp of colon
Rhinitis allergica
Tuberculosis
Tuberculosis
Cirrhosis of liver
Actinomycosis
Pneumonia
Herpes zoster after
kidney transplantation
Tuberculosis
Pneumonia
Crohn's disease and
polyposis of intestine
Pneumonia
Pneumonia
Pneumonia
Abscess of lung
Hepatitis
* The two measurements in Nos.
carried out on different days.
10
Residual
polarization
as percentage
ofthe
unstimulated
control value
86
74
87
85
86
87
76
85
86
102*
104
85
84
109*
105
87
86
82
87
85
>and 13 were
Solution, E. Merck, Darmstadt). This glass-
ware was washed x 10 with hot water and
then immersed for 8-12 h in chromic sul-
phuric acid. The glassware was then washed
x 10 in hot water, immersed 4-6 h in double-
distilled water, washed x 10 in double-
distilled water, dried and sterilized in hot air
(110°C).
Preparation of solutions.-The gradient
solution used to separate mononuclear blood
cells from the blood consisted of 24 parts of a
9% Ficoll (Pharmacia AB, Stockholm)
solution and 10 parts of a 35.7% Triosil 440
(Nyegaard & Co., A.S. Oslo) solution. The
Ficoll solution was passed through a millipore
filter (0.22 ,m) to sterilize it. It was important
that the density of the gradient was repro-
ducibly kept at 1-081-1-085 (at 200C). If the
gradient solution is to be kept for several
days, it should be contained in a dark bottle
at 40C, since it is sensitive to light. Iron for
removing phagocytic cells was the "Iron
powder 99.5% exiron carbonyl" commercially
available (Koch-Light Laboratories Ltd).
The phosphate-buffered saline (PBS) used
to wash the mononuclear blood cells and to
obtain an osmolality of 330 mosm had the
following composition per litre solution
(Dulbecco and Vogt, 1954): 0-2 g KCl, 0O2 g
52
KH2PO4, 2-91 g Na2 HPO4, 12H20, 95 g
NaCl, 6 ml ofa stock solution (2.658 g/100 ml)
CaCl2, 2H20, 5 ml of a stock solution (2-00 g/
100 ml) MgCl2. 6H20. (all salts from E. Merck,
Darmstadt). The PBS solution was sterilized
bysterile filtration through a filter with a pore
diameter of 022 ,um.
The phytohaemagglutinin (PHA) solution
was prepared as follows: Reagent Grade PHA
(Wellcome Ltd) powder (45 mg) was dis-
solved in 5 ml distilled water. Aliquots ofthis
solution were diluted x5, from which 0-1 ml
was added to the suspension of mononuclear
blood leucocytes before study (see below).
The fluorescein diacetate solution (FDA
Riedel - deHaen AG, Seelze - Hannover)
was prepared as follows: 50 mg FDA was
dissolved in 5 ml of glacial acetic acid. This
solution has to be as pure as possible and
should be kept at room temperature. 0-01 ml
of this FDA stock solution was added to
100 ml PBS to which 0 37 g of Na2HPO4.
12H2O were added. 25 ml of this FDA-PBS
is then added to 75 ml of PBS. This final
FDA-PBS solution should have an osmo-
lality of 330 mosm and a pH of 7-4.
Sampling and processing of blood.-20 ml
of blood was collected into a plastic syringe
rinsed with heparin. In the laboratory, this
blood was transferred into 2 glass screw-top
vials, each containing 0-1 g of iron powder.
The bottles were rotated (20-30 revs/min for
30 min) at 370C. Thereafter, the bottles are
placed over a magnet at a temperature of
20°C. Within about 10 min, the blood is free
fromiron-phagocytosing cells. Thenthesuper-
natant is removed and pipetted on to the
Ficoll-Triosil gradient at 20°C in 16 mm-
diameter glass tubes. Subsequently the
gradient is subjected to centrifugation at
550 g (at the expected interphase) for 20 min.
One or two layers of cells then become
visible. The upper layer or, if only one layer
is present, the upper part is removed. Thus,
the cells to be examined have in common a
particular density which allows them to
accumulate in this layer. These cells are
therefore termed "density-specified leuco-
cytes" or DS leucocytes. In the publications
of Cercek et al. (1974) these cells are referred
to as "SCM-responding lymphocytes". An
aliquot of the cell suspension is removed to
prepare smears for morphological examina-
tion (Fig. 1).
The remaining cell suspension is washed
twice in 0-9% NaCl and once in PBS (see
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
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FiG. I.-Leuicocyte concentrate smear of a cell suspension use(d for measurement after separation on the
Ficoll-Triosil gra(lient. Upper, x 800; lower, x 1728.
above). The cells are then counted, and a cell
suspension prepared with a concentration of
not more than 6 x 106 DS leucocytes.
Cell incubation with PHA.-Aliquots of
1 ml of the cell suspension were incubated
with 01 ml of PHA solution prepared as
described above for 45-60 min at 37°C.
Fluorescent probe.-Fluorescein diacetate
(FDA) is a non-fluorescent but fluorogenic
substrate. It is transformed to fluorescein by
enzymatic hydrolysis. It is this special
feature of FDA which allows one to perform
measurements in cell suspension. The fluor-
escence spectrum of fluorescein inside the
cell is a typical broad emission spectrum with
an emission maximum at 515 nm similar to
that of fluorescein in solution. According to
the suggestion of Cercek and Cercek (1977),
the polarization measurements were per-
formed at 510 nm.
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Measurement of the degree ofpolarization.-
The degree of polarization was measured
using a Schoeffel RRS-1000fluorescence spect-
rometer. A schematic representation of the
measuring device is given in Fig. 2. Irradia-
tion is performed with a 1OOOW xenon high-
pressure lamp via a double monochromator at
a wavelength 473 nm. The irradiation slit
was adjusted to 20 nm bandwidth. A Nicol-
Prisma was used as polarizer so orientated
that the incident light was polarized in a
vertical direction. The cuvette was kept at
27°C in a thermostated holder. The emission
light at 510 nm was observed via an analyser
and a second monochromator with a band
width of 10 nm. A non-fluorescent polaroid
HN38 foil proved to be sufficient as analyser.
a)
c
4)
time Esecl
FIG. 3. Time dependence of fluorescence
intensity of cell suspension for parallel (II)
and perpendicular (Ij) orientation of the
analyser with respect to the polarizer.
The fluorescence intensity was observed
alternatively with the analyser oriented
parallel (Ijl) and perpendicular (IJ) to the-
orientation of the incident light. The orienta-
tion was changed manually. A typical
registration curve is given in Fig. 3. The
increase in the total emission intensity as a
function of time reflects the diffusion of FDA
into the cell and its hydrolysis after mixing
the cell suspension and the FDA solution.
After 300 sec the solution was removed from
the cuvette and filtered carefully through a
Millipore filter (Millipore Corp., Bedford,
Mass.) (0-22 ,um). The filtration was per-
formed under reduced pressure of 500-600
mmHg, using a pressure-reducing device
(Mityval, Neward Die and MFG, USA). The
fluorescence intensity of the filtrate shows
that a large portion offluorescein diffuses out
of the cell during the measurement (Fig. 3).
The experimental curves were analysed in
terms of the so-called degree of polarization,
determined as:
I1-GIL
P=I1 +GIl (1)
where I H and IL1 are the intensities measured
with the analyser orientated parallel and
perpendicular to the polarizer. Since I 11 andII
are the differences in intensity between
filtrate and cell suspension (Fig. 3) a correc-
tion factor G has to be introduced into
Equation (1). G is the self-polarization of the
instrument, and was determined as 1 0171
according to the method described by Chen
and Bowman (1965).
RESULTS
The results of the study of the fluores-
cence-polarization changes of human DS
leucocytes are given in Tables I, II and
III for cells from healthy controls,
patients with malignant tumours and
others with non-neoplastic diseases. The
results are expressed as the reduction in
the degree of polarization, comparing DS
leucocytes without PHA stimulation to
those with PHA stimulation. This value is
identical to the "SCM-reduction" used
by Cercek et al. (1974). The results are
plotted in the form of histograms in Fig. 4
and the following comments may be made.
Fig. 4a summarizes the first 32 measure-
ments out of54 DS leucocyte samples from
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FiG. 4. Frequency distribution of change in
clegiree of polarization. Controls are cells
from same person but not treated with
PHA. The tests include all measurements
presented in Tables TI andl III.
32 "normal controls". It can be seen that
the reduction in the degree of polarization
after PHA stimulation ranges from 10 to
300. Accordingly, the residual polariza-
tion (the polarization after stimulation
related to the unstimulated value) lies
between 73 and 9700 with an average of
80%. There was no value in this group
resembling that seen in patients with
malignant disease.
Fig. 4b summarizes the 20 DS leucocyte
measurements obtained in 20 patients
with established and histopathologically
certified malignancy. It can be seen that
(with the exception of one patient) there
is no reduction in the fluorescence-
polarization response to PHA in the DS
leucocytes. All values except one fall
between 99% and 106%, with an average
of 102%. The one exception refers to a
patient with malignant melanoma. The
primary tumour was located at the foot.
The tumour was removed surgically, and
the lymph nodes in the groin did not show
any metastasis. In this case, no blood was
obtained before surgery, but 1 and 13 days
afterwards. In both measurements, the
DS leucocytes responded normally, and
the residual polarization was 89 and 88%
respectively.
Fig. 4c summarizes the 18 measurements
of the DS leucocyte suspensions without
and after PHA stimulation in 18 patients
with non-neoplastic diseases. Except in 2
patients, the DS leucocytes responded as
in healthy controls. The residual polariza-
tion was 74-87%0, with an average of 83%.
In the 2 exceptions, 4 measurements
were made, agreeing well with each other.
These measurements showed a lack of
response to PHA, so that the values were
between 102 and 1090%, and hence in the
range typical for DS leucocytes from
patients with malignancy. The clinical
problems of the respective patients will be
considered further in the disculssion.
DISCUSSION
Cercek et al. (1974,) and Cercek and
Cercek (1974, 1975, 1976) reported on the
possibility of measuring the response of
lymphocytes to the actions of mitogens
such as PHA or to cancer basic protein
(CaBP) by means of fluorescence-polariza-
tion changes. They reported that lympho-
cytes from normal huiman beings and from
patients with non-neoplastic diseases res-
ponded to PHA stimulation wTith an im-
mediate decrease in fluorescence polariza-
tion, which decrease was absent from
lymphocytes from patients with neo-
plastic diseases. In contrast, lymphocytes
from healthy donors did not respond to
stimulation with CaBP while lymphocytes
from patients with neoplastic diseases did.
These authors suggested that the changes
in fluorescence polarization reflect the
changes in physical organization of the
cytoplasmic matrix at the molecular level,
and that they are the results of physical
interaction between macromolecules such
as proteins, water molecules and solutes.
A decrease in the degree of fluiorescence
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polarization would be equivalent to an
increase in the microfluidity of the cyto-
plasmic matrix.
In our studies, we were able to confirm
that one can measure an immediate
decrease in the fluorescence polarization in
mononuclear blood cells of healthy donors
and of nearly all patients with non-
neoplastic diseases, after incubation of
the blood with PHA. In contrast, no such
changes are seen in patients with histo-
logically verified neoplasia.
However, in the light of the discussion
during a recent workshop (Bagshawe,
1977) that addressed itself (among several
topics) to the possibilities and limitations
of the SCM test, a few comments may be
justifiable.
"Specficity" of the ob8erved chanqe8
In the human beings studied in our
group, 2 out of 18 persons in the group of
"non-neoplastic diseases" had leucocytes
which did not respond with a decrease in
fluorescence polarization after incubation
with PHA. In a publication ofCercek et al.
(1974), there was also one healthy donor
whose lymphocytes did not respond to
PHA, as in patients with cancer. They sug-
gested this observation to be either a
"false positive", or a case of early malig-
nant growth without clinically detectable
signs and symptoms. Our two "false
positive" cases are of particular interest.
We had specially selected patients with
diseases that involve immune and/or
inflammatory reactivity. However, none
ofthese donors, except the 2 persons men-
tioned, gave a fluorescence reaction similar
to that in patients with confirmed neo-
plasia. One of these patients had a virus
infection (Herpes zoster) after a kidney
transplantation 4 years ago and has had
immunosuppressive therapy (cyclophos-
phamide) ever since. It is known that the
probability of developing cancer is signi-
ficantly increased in patients with kidney
transplantation and immunosuppressive
therapy (Sterioff et al., 1975). Thus, unless
this case is a true "false positive", one may
suspect a neoplasm before it is detected
clinically. Thus this patient needs to be
followed up carefully. The second patient
without a certified malignant tumour, but
with a fluorescence-polarization response
as seen in patients with neoplasia, suffered
from Crohn's disease. This disease, which
can be described as a regional ileitis, is a
chronic, localized inflammation of the
terminal portion of the small intestine. In
this case the typical radiological signs
were detected not only in the colon but
also in large segments of the small bowel
and stomach. It is also known that there is
an increased probability in these patients
ofdeveloping cancer (Weedon et al., 1973).
Thus again we may be dealing with a
patient with cancer before it has been
demonstrated by the clinical methods
available. It will be interesting to follow
this patient through the development of
his disease. On the other hand, one out of
20 patients with histologically verified
cancer (Table I) showed a fluorescence-
polarization response similar to that in
lymphocytes from healthy controls. This
patient suffered from a melanoma. Un-
fortunately, blood was obtained only 1
and 13 days after surgery. During surgery,
the tumour, located on the foot, was
completely removed and the surgeons
considered this patient free from recog-
nizable disease. Thus, the question is
whether this case has to be considered a
"false negative" or whether it is similar to
those cases of Cercek et al. (1975) that
return to normal response to PHA and
CaBP after successful removal of a
tumour. In their series, a return to normal
response was already under way 24 h
after removal of malignant tissue and con-
sidered to be due, perhaps, to a short
half-life of receptors for CaBP.
Cell-population considerations
In previous papers, the Cerceks (1974,
1975, 1976) used the word "lymphocyte"
to describe the cells in the cell suspension
that were measured by the fluorescence-
polarization technique. The common de-
nominators ofthe leucocytes in suspension
which were used to measure fluorescence-
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polarization changes are their density and
the absence of iron-ingesting macro-
phages. It is clear from previous publica-
tions, and from our work, that cells were
used that can be collected in a Ficoll-
Triosil gradient with a density of 1 081-
1*085 (at 20TC). Furthermore, cell suspen-
sions were studied, from which those cells
wereeliminated thathadingested carbonyl
iron and could be removed by means of a
magnet. Counting the cells in a counting
chamber certainly placed more than 9000
of the cells into the "mononuclear"
category and one may be tempted to use
the simplified term "lymphocyte". How-
ever, when the cells are examined in a
leucocyte smear, one observes that the
cell suspension contains a mixture of typi-
cal lymphocytes (80-90%) and other
mononuclear cells such as monocytes
(5-10%). There was also contamination
with some segmented neutrophils and
erythrocytes (3-7°/). Thus, in further
work, one should investigate the fluores-
cence-polarization response of the various
cell types that are present in the cell sus-
pension measured, and find out the reac-
tions of lymphocytes and monocytes with
densities other than those considered so
far. However, it may be that a particular
type of cell is not involved, but that leuco-
cytes of a variety of cell lineages can carry
receptors that allow cells to respond with
fluorescence-polarization changes or not,
when exposed to mitogens such as PHA,
or to proteins such as CaBP.
In this context the recent observations
of Cercek and Cercek (1976) measuring
fluorescence-polarization changes in single
cells are of interest. They could show that
in healthy donors, only 45-54% of the
lymphocytes respondwith adecrease in the
SCM to PHA stimulation, and as few as
15-23o of the lymphocytes of cancer
patients. Thus, it appears that it is of
particular interest and importance to
further characterize, morphologically and
functionally, those cells that do anddonot
respond to incubation with mitogens or
proteins, such as CaBP, with fluorescence-
polarization changes.
Methodological problems
It was ofinterest that several groups of
investigators were unable to reproduce
uniformly the published SCM test data
(Bagshawe, 1977). We also had difficulties
in our group. However, with the method-
ology described, we now seem to be able to
obtain consistent and reproducible results.
It should be stated, however, that meticu-
lous care in the preparation of the test
appeared to be of paramount importance.
All glassware that will come into contact
with the cells to be examined requires
particular handling. In addition, we ob-
served how important it is to use the solu-
tions necessary for the test in the composi-
tion outlined in this paper. In particular,
the PBS solution required 10-3 M CaC12
in order to give satisfactory results.
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